mutase, dopamine 3-hydroxylase, peptide a-amidating enzyme, and lysyl oxidase (1) . These copper-dependent enzymes are crucial to several processes of oxidative metabolism, including respiration, free-radical detoxification, neurotransmitter synthesis, and the maturation of connective tissue. Another important copper protein is ceruloplasmin, an abundant serum glycoprotein that contains most of the copper in the circulation (1) . Ceruloplasmin has a ferroxidase activity that appears to be required for the delivery of iron into the circulation (2) , but the biochemical basis of this requirement is not understood. The loading of ceruloplasmin with copper is defective in Wilson disease (3, 4) . Recently, the genes responsible for Wilson disease and a closely related disorder, Menkes disease, were cloned and identified as putative copper-transporting P-type ATPases (5) (6) (7) (8) (9) (10) .
The yeast Saccharomyces cerevisiae is an excellent model organism for studying many fundamental processes of eukaryotic cells, due in large part to the clarity that yeast genetics brings to the analysis of protein function (11) . Because of the fundamental importance of oxidative metabolism to eukaryotic cells, it is reasonable to expect that mechanisms of copper metabolism may be well conserved between human cells and yeast. A plasma membrane protein required for high-affinity copper uptake has been identified in yeast, where it is encoded by the CTR1 gene (12) . CTRI mutants have several phenotypes attributable to copper deficiency, including loss of highaffinity iron uptake (12, 13) . Growth of cells in coppersupplemented medium reverses these phenotypes. Reversal of the iron uptake defect by copper, however, requires the FET3 gene (12, 14) . FET3 encodes a predicted transmembrane protein with significant homology to copper-dependent oxidases such as ceruloplasmin, ascorbate oxidase, and laccase (14) . These observations suggest that Fet3p is a copper protein that receives its copper through a mechanism involving Ctrlp. Because of the homology of Fet3p with ceruloplasmin, it is perhaps not surprising that yeast also contain a homologue of the human Wilson and Menkes disease gene products. Indeed, the predicted product of the yeast CCC2 gene possesses both the motifs common to P-type ATPases and two of the copper interaction motifs found in its mammalian counterparts (15) .
In this paper we characterize copper-dependent phenotypes in cells lacking a functional CCC2 gene. We show that the CCC2 gene product plays a specific role in the copperdependent activation of a ceruloplasmin-like oxidase activity of Fet3p, an activity that we demonstrate resides outside of the cytosol. Thus, CCC2 encodes a protein that delivers cytosolic copper to the lumen of an internal organelle, analogous to the proposed mechanisms implicated in Wilson disease and Menkes disease (16, 17) .
MATERIALS AND METHODS Yeast Strains. Strain 1 is YPH252 (MA Ta, ura3-52 lys2-801 ade2-101 trpl-Al his3-A200 1u2-A1) (18) and is congenic with strains 2 through 6. Strain 2: the CTR1 gene was replaced with the LEU2 gene by using the plasmid AMTR-LEU (13) . Strain 3: the CCC2 gene was disrupted at the BspEI site by the URA3 gene by using the plasmid E5-URA3.4. Strain 4: the FET3 gene was replaced with the TRP1 gene by transforming a diploid homozygous parent of strain 1, YPH274 (18) , with a DNA fragment generated by PCR to contain 50 bp of FET3 sequence at each end flanking the TRP1 gene (19) . Sporulated cells were dissected and tested for tryptophan prototrophy. The cells chosen were MATa. Strain 5: the CCC2 gene was disrupted (as above) in strain 4. Genotypes for strains 2 through 5 were confirmed by PCR using primers derived from the inserted marker gene and flanking genomic sequences.
Strain 6: a rho0 mitochondrial genotype in strain 1 was created as described (20) . Strain 7 (MATa, his3-200 leu2 trpl-101 ura3-52 ade5), also called 2908, was a gift from R. Wickner (National Institutes of Health). Strain 8 was derived from strain 7 by deletion of CCC2 as described (15) . Strain 9 is the protease-deficient strain BJ2168 (MATa, prcl-407 prbl-1122 pep4-3 leu2 trpl ura3) (21) transformed with the episomal URA3-based plasmid YEpFet3ET18 (Fet3p-HA). This plasmid contains the FET3 gene with sequences specifying the hemagglutinin (HA) epitope (22) added to the 3' end of the FET3 coding region by overlapping PCR; it was a gift from D.
Abbreviations: HA, hemagglutinin; Endo H, endoglycosidase H.
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Eide (University of Minnesota) and J. Kaplan (University of Utah).
Identification of Candidate Genes Encoding P-Type ATPases. Degenerate oligonucleotides [GCGGAYAARACIG-GNAC (5' primer) and CCGTCRTTIATNCCRTC (3' primer)], derived from conserved motifs in P-type ATPases [DKTGT and DGIND, respectively (23)], were used in PCRs to amplify sequences from genomic DNA isolated from S. cerevisiae strain F113 (24) . Cloned DNA was analyzed by Southern blotting and sequenced. Data base searches for homologous proteins were performed by using the Swiss-Prot protein data base (version 29.0) and the FASTA program (Genetics Computer Group, version 7) (25, 26) .
Growth and Iron Uptake Assays. Cells were washed in water and placed at a dilution of 1000 cells per drop on agar medium containing 2% glucose (YPD) or 3% ethanol (YE) (27) , alone or with 1 mM ferric ammonium sulfate or 0.5 mM cupric sulfate as indicated and grown at 30°C for 3 days before photography. High-affinity iron uptake was determined as described previously (12).
13-Galactosidase Assays. For studies of copper-dependent
CTRl-lacZ activity, cells were grown in microtiter plates at 30°C for 14 hr in a synthetic defined medium (YNB, Bio 101) lacking iron and copper, supplemented with 50 mM hemisodium salt of 2-morpholinoethanesulfonic acid at pH 6.1, 10 ,M ferric ammonium sulfate, copper in the indicated concentration, and media supplements to maintain selection for the CTRJ-lacZ plasmid. 13-Galactosidase was assayed in permeabilized cells as described (13, 28) .
Cell Homogenization and Fractionation. Exponentially growing cells were washed and homogenized in ice-cold buffer [150 mM NaCl/25 mM Tris-HCl, pH 7.4/1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride (ICN)/10 ,M pepstatin A/30 ,uM leupeptin, and additives as indicated] by mixing with glass beads. After removal of large particles, homogenates were centrifuged (16,000 x g, 4°C) for 30 min. Pellets were washed in buffer, resuspended in buffer containing 1% Triton X-100, and centrifuged for 30 min to yield a clarified extract. Extracts were stored at -20°C.
Western Blotting. Samples were heated in Laemmli sample buffer containing dithiothreitol and analyzed for the HA epitope by Western blotting using rabbit antiserum HA1l (Berkeley Antibody, Richmond, CA) at a dilution of 1:5000. Bound antibody was detected as enhanced chemiluminescence (Amersham). without prior heating by SDS/PAGE. The gel was then equilibrated with 50 vol of 0.05% Triton X-100 in 10% (wt/vol) glycerol, soaked for an equal time in 5 vol of 3 mM pphenylenediamine dihydrochloride (Sigma) (29)/100 mM sodium acetate, pH 5.7/1 mM NaN3, and air-dried in the dark at 23°C for 24 hr before photography.
RESULTS
Cloning of Genes Encoding S. cerevisiae P-Type ATPases. We used PCR to identify genes encoding P-type ATPases in S. cerevisiae, using S. cerevisiae genomic DNA as template and degenerate oligonucleotide primers derived from two conserved amino acid motifs common to P-type ATPases (23) . This approach yielded the three previously identified P-type ATPase genes in S. cerevisiae, PMR1, PMA1, and ENA1/PMR2 (30) , as well as a fourth gene, whose predicted product contained two of the GMTCXXC amino acid motifs (31) found in the Wilson and Menkes disease gene products. This fourth gene proved to be identical to CCC2, a gene recently identified as a suppressor of calcium sensitivity in CSGI mutants (15, 32) . Comparison of the entire CCC2-predicted amino acid sequence with a protein data base revealed that the CCC2 gene product shares significant similarity with the Wilson disease and Menkes disease gene products (31% identity over 604 residues and 29% over 814 residues, respectively).
Disruption of the CCC2 Gene-Metal-Correctable Phenotypes. To examine the role of the CCC2 gene, a CCC2 disruption mutant was compared with two congenic mutant strains for the ability to grow on an ethanol-based medium (YE), a test of respiratory competence (27) . These strains had disruptions in either CTR1, essential for high-affinity copper uptake (12), or FET3, essential for high-affinity iron uptake (12, 14) . As shown in Fig. 1 , each of these mutations resulted in impaired growth on ethanol medium. The growth deficiency for each could be corrected by a particular pattern of metal supplementation. The CTR1 mutant could be rescued by high concentrations of copper, as expected, but not by iron, presumably because copper is required for respiration as' a cofactor in cytochrome-c oxidase (1) in addition to iron. Conversely, the FET3 mutant could only be rescued by high concentrations of iron. Surprisingly, the CCC2 mutant could be rescued by high concentrations of either copper or iron. High-affinity ferrous transport activity was undetectable in all three mutant strains. In all of these cases, the ability of added metal to correct metal deficiency is presumably due to the (1995) ability of the high levels of added metal to gain access to the cell through mechanisms other than specific high-affinity uptake pathways. In the CTR1 or CCC2 mutants, ferrous transport could be recovered by growth in the presence of 50 ,uM added copper (Fig. 1) . Copper could not rescue ferrous transport in either the FET3 mutant or in CTR1 or CCC2 mutants with deletions in FET3, consistent with Fet3p functioning downstream of both Ctrlp and Ccc2p.
The CCC2 mutant thus resembled the CTR1 mutant in that its defects in ethanol-based growth and iron uptake were correctable by copper (Fig. 1) . The CTR1 mutant is deficient in copper uptake from the environment to the cytosol (12, 13) . We therefore evaluated the cytosolic copper pool of the CCC2 mutant by using a copper-responsive reporter gene construct, CTR1-lacZ (13) . As shown in Fig. 2 , nanomolar concentrations of copper added to the growth medium equally repressed lacZ expression in both a CCC2 mutant and its wild-type parent, indicating that cytosolic copper levels were not significantly decreased. By comparison, the repression of lacZ from the CTR1-lacZ plasmid in a CTRI mutant required 300-fold higher concentrations of copper. Radioactive copper uptake and cytosolic Cu,Zn-dependent superoxide dismutase activity were also normal in the CCC2 mutant grown in YPD medium (D.S.Y. and A.D., unpublished observations), in contrast with the greatly diminished activities in CTRI mutants (12, 13) .
Fet3p: An Extracytosolic Transmembrane Oxidase. CCC2 mutants thus presented a paradox: the copper-correctable phenotypes suggested copper deficiency, and yet external copper uptake and cytosolic copper levels were not low. This could be explained if CCC2 were required for the delivery of cytosolic copper to an intracellular membrane-bound compartment. We therefore asked whether Fet3p is an extracytosolic copper protein. Reexamination amino terminus of the predicted protein. This was followed by a large hydrophilic domain separated from a short carboxylterminal hydrophilic tail by a predicted transmembrane domain. Fourteen potential N-glycosylation sites and the four proposed copper-binding motifs (14, 33) were identified within the large hydrophilic domain. Direct biochemical proof of the protein's orientation was sought. We studied Fet3p by Western blotting against a carboxyl-terminal HA epitope tag (22) . The tagged protein (Fet3p-HA) fully complemented the iron-uptake defect in a FET3 deletion mutant. All Fet3p-HA was localized to the membrane fraction of cell homogenates and migrated more rapidly on SDS/PAGE after treatment with endoglycosidase H (Endo H) (Fig. 3A) , demonstrating that Fet3p is a membranebound glycoprotein and confirming its predicted topology. The homology between Fet3p and ceruloplasmin had suggested that Fet3p might be a copper-dependent oxidase (14) . When a modified in situ SDS/PAGE assay for ceruloplasmin (29) was used, a single band of oxidase activity was observed. This activity comigrated with the HA-tagged protein, detected by Western blotting, with or without Endo H treatment (D.S.Y., unpublished observations). The oxidase activity was absent from a FET3 mutant and was repressed in cells grown with added iron (Fig. 3B) , consistent with the transcriptional repression of FET3 by iron (14) . Oxidase activity was absent from cells grown in the presence of the copper chelator bathocuproinedisulfonate (BCS), despite normal levels of Fet3p (Fig. 3B) . Oxidase activity was also absent from the CCC2 mutant grown in YPD medium (Fig. 3C) . That Fet3p levels were normal in these cells was demonstrated by the ability to fully reconstitute oxidase activity in vitro by homogenizing the cells in the presence of copper (Fig. 3C) . Oxidase activity in the CCC2 mutant could also be fully restored in vivo by growth of the cells in medium supplemented with high levels of copper (Fig. 3C) , paralleling the ability of copper to restore both iron uptake and respiratory competence (Fig. 1) .
DISCUSSION
Previous data (12, 14) revealed an essential role for Fet3p in the high-affinity uptake of external ferrous iron. We have presented biochemical evidence that the FET3 gene indeed encodes a ceruloplasmin-like oxidase, as predicted, and that copper, Ctrlp, and Ccc2p are all required for both Fet3p oxidase activity and high-affinity ferrous transport. Essential to understanding this pathway is the characterization of the topology of the Fet3 protein. The biochemical data reported here clearly localize the oxidase domain to the lumenal or extracellular side of the membrane.:A scheme for the coupled pathways of iron and copper uptake in S. cerevisiae is shown in Fig. 4 . Ferric iron is first reduced to ferrous iron outside the cell by either of two externally directed ferric reductases (Frelp and Fre2p) (34, 35) . The reduced iron is then transported into the cell by a ferrous transporter that has not yet been molecularly identified. Ferrous transport requires the copper-dependent oxidase activity of Fet3p. In turn, Fet3p receives its copper from Ctrlp and Ccc2p acting in sequence to transport copper first across the plasma membrane and then out of the cytosol across one or more intracellular membranes. Ctrlp, localized to the plasma membrane, is required for high-affinity copper uptake into the cell. Ctrlp provides copper to several cellular targets, including Fet3p (12, 14) .
Ccc2p, presumably localized to the secretory pathway, is necessary for delivering copper from the cytosol to the site at which Fet3p is loaded with copper. The scheme shown in Fig.  4 suffices to explain why either copper or iron corrects the respiratory deficiency of the ccc2 mutant. In these cells, the respiratory deficiency results entirely from lack of sufficient iron. The iron deficiency, in turn, is due to the selective failure to provide copper to Fet3p. In contrast, CTR1 mutants are oxidases, appear to play in the mobilization of iron across membranes. In copper-deficient swine, ceruloplasmin deficiency results in functional iron deficiency (39) . These animals accumulate iron in enterocytes and reticuloendothelial cells. The iron deficiency presumably results from the inability to mobilize the iron from these sites. In Wilson disease, severe ceruloplasmin deficiency is associated with signs of iron deficiency (2) . Thus, in the mammalian case, the extracellular copper-dependent oxidase appears to be involved in the movement of iron out of cells. Recently, Gitlin and colleagues (40) have identified patients with defects in the ceruloplasmin gene. These patients have neurologic abnormalities associated with deposition of iron in cells in the central nervous system, again pointing to the possible role of an oxidase in iron mobilization. The intriguing analogies between these clinical situations and the ferrous uptake defects in the respective yeast CTR1, CCC2, and FET3 mutants suggest that the mechanisms of copper and iron transport in eukaryotes are well conserved and that abnormalities of copper metabolism should be considered as possible contributing factors in clinical disorders of iron homeostasis.
